Analyst Ratings for Emergent BioSolutions (EBS)
EBS Rating Summary
EBS Price Target Summary
- Highest: $15.00 (TD Cowen)
- Lowest: $5.00 (Benchmark)
- Average: $8.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.50 (+244.1%)
* Over Last 12-Mos
Rating Score: 6.3 / 10 Percentile Rank: 67%
Rating Score: 6.3 / 10 Percentile Rank: 67%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/7/2024 | Benchmark | Robert Wasserman | Upgrade | Buy (Hold) |
5.00 (N/A) |
3.26 (2.47) |
-24.23% | Details |
11/20/2023 | JPMorgan | Jessica Fye | New Coverage | Underweight (N/A) |
N/A (N/A) |
2.12 (2.47) |
16.51% | Details |